Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

March 31, 2034

Conditions
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in ChildrenOtotoxicity
Interventions
DRUG

carboplatin

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

methotrexate

DRUG

vincristine sulfate

PROCEDURE

adjuvant therapy

PROCEDURE

cognitive assessment

PROCEDURE

magnetic resonance imaging

PROCEDURE

magnetic resonance spectroscopic imaging

PROCEDURE

quality-of-life assessment

Trial Locations (10)

B4 6NH

Birmingham Children's Hospital, Birmingham

CB2 2QQ

Addenbrooke's Hospital, Cambridge

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

L12 2AP

Royal Liverpool Children's Hospital, Alder Hey, Liverpool

WC1N 3JH

Great Ormond Street Hospital for Children, London

M27 4HA

Royal Manchester Children's Hospital, Manchester

NG7 2UH

Queen's Medical Centre, Nottingham

S10 2TH

Children's Hospital - Sheffield, Sheffield

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

G3 8SJ

Royal Hospital for Sick Children, Glasgow

All Listed Sponsors
lead

Children's Cancer and Leukaemia Group

OTHER